
PULMONARY THROMBOEMBOLISM FOLLOWING RADIOFREQUENCY
ABLATION OF THE ATRIOVENTRICULAR
NODE IN A PATIENT HETEROZYGOUS FOR THE FACTOR
V LEIDEN AND THE MTHFR C677T MUTATIONS Pešut DP1,2*, Raljević SV2, Kontić MDj2, Božić DZ2, Buha IB2, Stević RS1,3 *Corresponding Author: Dragica P. Pešut, School of Medicine University of Belgrade; Clinical Centre of
Serbia, Institute of Lung Diseases and Tuberculosis, Research and Epidemiology Department, 11000 Belgrade,
Visegradska 26/20, Serbia; Tel.: +381-11-361-5561; Fax: +381-11-268-1591;
E-mail: dragica. pesut@gmail.com page: 51
|
CASE REPORT
A 41-year-old Caucasian male, smoker (20 cigarettes
daily for 20 years), was admitted 2 weeks after
an episode of persistent sharp chest pain, fever and
fatigue, which occurred soon after slow pathway radiofrequency
ablation of the AV, performed because
of arrhythmia. There was no family history of thrombosis
but no investigation for family thrombophilia
was performed.
He was afebrile, with a heart rate of 80 beats·min-1,
blood pressure 140/90 mmHg, and a respiratory rate
of 18 breaths·min-1. Routine laboratory findings were
within normal ranges. Arterial blood gas analysis
showed hypoxemia with signs of hyperventilation –
PaO2: 9.2 kPa (standard value 11.28-12.18 kPa), Pa-
CO2: 4.5 kPa, saturated oxygen: 95%, pH: 7.47. An
electrocardiogram gave normal results. Standard postero-
anterior chest X-ray showed obtuse right costophrenic
angle and laminar atelectasis in the right lower
lung lobe (Figure 1). D-dimer level, measured by the
immunoturbidometric method (Dade-Behring, Deerfield,
IL, USA), was 261 μg·L-1 (normal <250 μg·L-1).
A perfusion lung scan showed massive bilateral defects
in middle and lower parts of the right lung and
segmental defects in basal part of the left lung, which
did not correlate with the changes in the chest X-ray
(Figure 2). The ventilation scan was not available.
Doppler ultrasonography of the lower limb veins
gave negative results for deep venous thrombosis (DVT).
Computed tomography showed a thrombotic mass (12
mm diameter) in the pulmonary artery. Echocardiography
showed increased mean blood pressure in the
right ventricle (27mmHg). Blood tests for antinuclear
antibodies (ANA), antineutrophil cytoplasmic antibodies
(ANCA) and antiphospholipid antibodies were
negative and the level of anticardiolipin antibodies was
not elevated. Sputum smear was negative for pathogenic
agents including Mycobacteria. Hematological
investigation revealed normal activities of protein C,
protein S and antithrombin III. DNA analyses for FV
Leiden, FII G20210A and MTHFR C677T mutations
were performed by polymerase chain reaction (PCR)
as previously described [5,6] at the Institute of Molecular
Genetics and Bioengineering, Belgrade, Serbia. The
PCR analyses for FV Leiden and MTHFR C677T were
positive, and both indicated heterozygotes.
Therapy started with intravenous heparin, followed
by warfarin, keeping the international rate (INR) of prothrombin time in therapeutic range, i.e.,
INR = 2-3. The lifelong oral anticoagulant treatment
was recommended. The patient’s clinical state gradually improved, disease outcome was favorable and
computed tomography showed no thrombotic mass in
the pulmonary artery after 3 months. During a 2-year
follow-up, he had no new thrombotic episodes.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|